TY - JOUR
T1 - Prehypoxic clonidine administration improves vasomotricity of isolated rat aorta during reoxygenation
AU - Gourdin, Maximilien J
AU - Ponchau, Olivia
AU - Jamart, Jacques
AU - De Kock, Marc
PY - 2010
Y1 - 2010
N2 - BACKGROUND AND OBJECTIVE: Clonidine, an alpha-2 adrenoceptor (A2A) agonist, improves posthypoxic function of several organs in humans and animal models. Mechanisms underlying these effects are not fully understood. A competent vasomotricity during reperfusion participates in the organ's recovery. This study investigates the specific effect of clonidine administration before hypoxia on posthypoxic vasomotricity in a rodent model.METHODS: Isolated aortic rings from young rats were submitted to hypoxia/reoxygenation (20/40 min). Clonidine (10(-5) mol l(-1)), alone or with various receptor antagonists such as rauwolscine (specific A2A antagonist), ARC239 (A2B/C-prefering A antagonist), BRL44408 (A2AA antagonist), nitrogen oxide synthase inhibitor (Nω-nitro-L-arginine methyl ester) or cyclooxygenase inhibitor (indometacin), was administered in two randomized baths and washed out before hypoxia. Two other baths constituted the control group. In some experiments, clonidine was substituted by UK14.304 (A2A agonist). In all baths, posthypoxic endothelium-dependent dilatation (PED) and posthypoxic contraction were assessed.RESULTS: Clonidine improves PED (P = 0.002) and posthypoxic contraction (P = 0.001). Rauwolscine (P = 0.803) and ARC239 (P = 0.236) abolished clonidine-induced PED improvement. In the presence of BRL44408, clonidine increases posthypoxic endothelial dysfunction (P = 0.001). UK14.304 (P = 0.954) does not mimic the clonidine effect on PED. Concerning posthypoxic contraction, rauwolscine (P = 0.917), endothelial removal (P = 0.687), ARC239 (P = 0.118) or BRL44408 (P = 0.204) prevents the clonidine effect, but UK14.304 induces it (P = 0.005). Nω-Nitro-L-arginine methyl ester (P = 0.026) does not abolish it. Indometacin prevents it on PED and posthypoxic contraction (P = 0.678 and P = 0.851, respectively).CONCLUSION: Clonidine improves posthypoxic vasomotricity on isolated aortic rings. Concerning PED, two endothelial A2A subtypes are required. The clonidine effect on posthypoxic contraction requires endothelial A2A. Nitrogen oxide does not seem to be involved. Concerning the clonidine effect on PED and posthypoxic contraction, cyclooxygenase metabolites seem to be involved.
AB - BACKGROUND AND OBJECTIVE: Clonidine, an alpha-2 adrenoceptor (A2A) agonist, improves posthypoxic function of several organs in humans and animal models. Mechanisms underlying these effects are not fully understood. A competent vasomotricity during reperfusion participates in the organ's recovery. This study investigates the specific effect of clonidine administration before hypoxia on posthypoxic vasomotricity in a rodent model.METHODS: Isolated aortic rings from young rats were submitted to hypoxia/reoxygenation (20/40 min). Clonidine (10(-5) mol l(-1)), alone or with various receptor antagonists such as rauwolscine (specific A2A antagonist), ARC239 (A2B/C-prefering A antagonist), BRL44408 (A2AA antagonist), nitrogen oxide synthase inhibitor (Nω-nitro-L-arginine methyl ester) or cyclooxygenase inhibitor (indometacin), was administered in two randomized baths and washed out before hypoxia. Two other baths constituted the control group. In some experiments, clonidine was substituted by UK14.304 (A2A agonist). In all baths, posthypoxic endothelium-dependent dilatation (PED) and posthypoxic contraction were assessed.RESULTS: Clonidine improves PED (P = 0.002) and posthypoxic contraction (P = 0.001). Rauwolscine (P = 0.803) and ARC239 (P = 0.236) abolished clonidine-induced PED improvement. In the presence of BRL44408, clonidine increases posthypoxic endothelial dysfunction (P = 0.001). UK14.304 (P = 0.954) does not mimic the clonidine effect on PED. Concerning posthypoxic contraction, rauwolscine (P = 0.917), endothelial removal (P = 0.687), ARC239 (P = 0.118) or BRL44408 (P = 0.204) prevents the clonidine effect, but UK14.304 induces it (P = 0.005). Nω-Nitro-L-arginine methyl ester (P = 0.026) does not abolish it. Indometacin prevents it on PED and posthypoxic contraction (P = 0.678 and P = 0.851, respectively).CONCLUSION: Clonidine improves posthypoxic vasomotricity on isolated aortic rings. Concerning PED, two endothelial A2A subtypes are required. The clonidine effect on posthypoxic contraction requires endothelial A2A. Nitrogen oxide does not seem to be involved. Concerning the clonidine effect on PED and posthypoxic contraction, cyclooxygenase metabolites seem to be involved.
KW - Adrenergic alpha-2 Receptor Agonists
KW - Animals
KW - Aorta
KW - Cell Hypoxia
KW - Clonidine
KW - Endothelium, Vascular
KW - Male
KW - Muscle Contraction
KW - Oxygen
KW - Prostaglandin-Endoperoxide Synthases
KW - Rats
KW - Rats, Wistar
KW - Receptor, Adenosine A2A
KW - Vasodilation
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
U2 - 10.1097/EJA.0b013e32833b001c
DO - 10.1097/EJA.0b013e32833b001c
M3 - Article
C2 - 20523216
SN - 0001-5164
VL - 27
SP - 965
EP - 972
JO - Acta anaesthesiologica Belgica
JF - Acta anaesthesiologica Belgica
IS - 11
ER -